Nasopharyngeal carcinoma: The role of magnetic resonance imaging in diagnosis, staging, treatment, and follow-up

Topics in Magnetic Resonance Imaging

Volumn 18, Issue 4, 2007, Pages 225-235

  Glastonbury, Christine M ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Neuroradiology Section   (United States)

Author keywords

MRI; Nasopharyngeal carcinoma; Staging

Indexed keywords

BONE NECROSIS; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; EXTERNAL BEAM RADIOTHERAPY; FOLLOW UP; HUMAN; INTENSITY MODULATED RADIATION THERAPY; METASTASIS; MUCOSA INFLAMMATION; MYOPATHY; MYOSITIS; NASOPHARYNX CARCINOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; OTITIS MEDIA; PAROTITIS; PATIENT CARE; PRIORITY JOURNAL; REVIEW; SURVIVAL RATE; XEROSTOMIA;

CARCINOMA; DEMOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NASOPHARYNGEAL NEOPLASMS; NEOPLASM STAGING;

EID: 34748844517     PISSN: 08993459     EISSN: None     Source Type: Journal    
DOI: 10.1097/RMR.0b013e3181572b3a     Document Type: Review

References (40)

1. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74-108.
2. Parkin DM, Muir CS, Whelan SL, et al, eds. Cancer Incidence in Five Continents. Vol VI. Lyon, France: IARC; 1992.
3. Chia KS, Lee HP. Epidemiology. In: Chong VFH, Tsao SY, eds. Nasopharyngeal Carcinoma. Hong Kong: Armour Publishing;1997:1-5.
4. Vokes EE, Liebowitz DN, Weichselbaum RR. Nasopharyngeal carcinoma. Lancet. 1997;350:1087-1091.
5. Henderson BE, Louie E, SooHoo Jing J, et al. Risk factors associated with nasopharyngeal carcinoma. N Engl J Med. 1976;295:1101-1106.
6. Yu MC, Mo CC, Chong WX, et al. Preserved foods and nasopharyngeal carcinoma: a case-control study in Guangxi, China. Cancer Res. 1988;48:1954-1959.
7. Williams EH, de-The G. Familial aggregation in nasopharyngeal carcinoma. Lancet. 1974;2:295.
8. Heussinger N, Buttner M, Ott G, et al. Expression of the Epstein-Barr virus (EBV) - encoded latent membrane protein 2A (LMP2A) in EBV-associated nasopharyngeal carcinoma. J Pathol. 2004;203:696-699.
9. King AD, Vlantis AC, Tsang RK, et al. Magnetic resonance imaging for the detection of nasopharyngeal carcinoma. AJNR Am J Neuroradiol. 2006;27:1288-1291.
10. Pathmanathan R. Pathology. In: Chong VFH, Tsao SY, eds. Nasopharyngeal Carcinoma. Hong Kong: Armour Publishing; 1997:6-13.
11. Ng WT, Lee AW, Kan WK, et al. N-staging by magnetic resonance imaging for patients with nasopharyngeal carcinoma: pattern of nodal involvement by radiological levels. Radiother Oncol. 2007;82:70-75.
12. Ng SH, Chang JT, Chan SC, et al. Nodal metastases of nasopharyngeal carcinoma: patterns of disease on MRI and FDG PET. Eur J Nucl Med Mol Imaging. 2004;31:1073-1080.
13. King AD, Ahuja AT, Leung SF, et al. Neck node metastases from nasopharyngeal carcinoma: MR imaging of patterns of disease. Head Neck. 2000;22:275-281.
14. Stambuk HE, Patel SG, Mosier KM, et al. Nasopharyngeal carcinoma: recognizing the radiographic features in children. AJNR Am J Neuroradiol. 2005;26:1575-1579.
15. Richey LM, Olshan AF, George J, et al. Incidence and survival rates for young blacks with nasopharyngeal carcinoma in the United States. Arch Otolaryngol Head Neck Surg. 2006;132:1035-1040.
16. American Joint Committee on Cancer. Pharynx. In: Greene FL, Page DL, Fleming ID, et al, eds. AJCC Cancer Staging Handbook. 6th ed. New York: Springer-Verlag; 2002:47-60.
17. Chung NN, Ting LL, Hsu WC, et al. Impact of magnetic resonance imaging versus CT on nasopharyngeal carcinoma: primary tumor target delineation for radiotherapy. Head Neck. 2004;26:241-246.
18. Ma J, Liu L, Tang L, et al. Retropharyngeal lymph node metastasis in nasopharyngeal carcinoma: prognostic value and staging categories. Clin Cancer Res. 2007;13:1445-1452.
19. Liu LZ, Zhang GY, Xie CM, et al. Magnetic resonance imaging of retropharyngeal lymph node metastasis in nasopharyngeal carcinoma: patterns of spread. Int J Radiat Oncol Biol Phys. 2006;66:721-730.
20. Som PM, Curtin HD, Mancuso AA. An imaging-based classification for the cervical nodes designed as an adjunct to recent clinically based nodal classifications. Arch Otolaryngol Head Neck Surg. 1999;125:388-396.
21. Som PM, Curtin HD, Mancuso AA. Imaging-based nodal classification for evaluation of neck metastatic adenopathy. AJR Am J Roentgenol. 2000;174:837-844.
22. Som PM, Curtin HD, Mancuso AA. A criterion for distinguishing level V nodes from clavicular nodes. Arch Otolaryngol Head Neck Surg. 2000;126:807.
23. Chiesa F, De Paoli F. Distant metastases from nasopharyngeal cancer. ORL J Otorhinolaryngol Relat Spec. 2001;63:214-216.
24. Teo PM, Kwan WH, Lee WY, et al. Prognosticators determining survival subsequent to distant metastasis from nasopharyngeal carcinoma. Cancer. 1996;77:2423-2431.
25. Lee AW, Law SC, Foo W et al. Retrospective analysis of patients with nasopharyngeal carcinoma treated during 1976-1985: survival after local recurrence. Int J Radiat Oncol Biol Phys. 1993;26:773-782.
26. Vikram B, Mishra UB, Strong EW, et al. Patterns of failure in carcinoma of the nasopharynx: failure at distant sites. Head Neck Surg. 1986;8:276-279.
27. Forastiere AA, Ang K, Brizel D, et al. Cancers of the nasopharynx. In: Head and Neck Cancers. NCCN Clinical Practice Guidelines in Oncology. Vol I. National Comprehensive Cancer Network (NCCN); 2006. Available at: www.nccn.org/professionals/physician_gls/PDF/head-and-neck.pdf. Accessed April 24, 2007.
28. Yen TC, Chang JT, Ng SH, et al. The value of 18F-FDG PET in the detection of stage M0 carcinoma of the nasopharynx. J Nucl Med. 2005;46:405-410.
29. Kumar MB, Lu JJ, Loh KS, et al. Tailoring distant metastatic imaging for patients with clinically localized undifferentiated nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2004;58:688-693.
30. Chang JT, Chan SC, Yen TC, et al. Nasopharyngeal carcinoma staging by (18)F-fluorodeoxyglucose positron emission tomography. Int J Radiat Oncol Biol Phys. 2005;62:501-507.
31. Chan SC, Ng SH, Chang JT, et al. Advantages and pitfalls of 18F-fluoro-2-deoxy-D-glucose positron emission tomography in detecting locally residual or recurrent nasopharyngeal carcinoma: comparison with magnetic resonance imaging. Eur J Nucl Med Mol Imaging. 2006;33:1032-1040.
32. Oh JL, Vokes EE, Kies MS, et al. Induction chemotherapy followed by concomitant chemoradiotherapy in the treatment of locoregionally advanced nasopharyngeal cancer. Ann Oncol. 2003;14:564-569.
33. Lee N, Xia P, Quivey J, et al. Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience. Int J Radiat Oncol Biol Phys. 2002;53:12-22.
34. Wolden SL, Chen WC, Pfister DG, et al. Intensity-modulated radiation therapy (IMRT) for nasopharynx cancer: update of the Memorial Sloan-Kettering experience. Int J Radiat Oncol Biol Phys. 2006;64:57-62.
35. Lee N, Garden A, Kramer A, et al. RTOG 0225 protocol. A phase II study of intensity modulated radiation therapy (IMRT) +/- chemotherapy for nasopharyngeal cancer. Available at: http://rtog.org/members/protocols/0225/ 0225.pdf. Accessed April 24, 2007.
36. O'Meara WP, Lee N. Advances in nasopharyngeal carcinoma. Curr Opin Oncol. 2005;17:225-230.
37. Bonner JA, Harari PM, Giralt J, et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med. 2006;354:567-578.
38. Spano JP, Busson P, Atlan D, et al. Nasopharyngeal carcinomas: an update. Eur J Cancer. 2003;39:2121-2135.
39. King AD, Ahuja AT, Yeung DK, et al. Delayed complications of radiotherapy treatment for nasopharyngeal carcinoma: imaging findings. Clin Radiol. 2007;62:195-203.
40. King AD, Yeung DK, Ahuja AT, et al. In vivo proton MR spectroscopy of primary and nodal nasopharyngeal carcinoma. AJNR Am J Neuroradiol. 2004;25:484-490.